[DOC] S4 Table. - PLOS,https://journals.plos.org/plosone/article/file%3Ftype%3Dsupplementary%26id%3D10.1371/journal.pone.0177310.s008
[DOC] S5 Table. - PLOS,https://journals.plos.org/plosone/article/file%3Ftype%3Dsupplementary%26id%3D10.1371/journal.pone.0177310.s009
[DOC] united states securities and exchange commission - BioNTech,https://investors.biontech.de/static-files/cacaf650-e2e8-4be8-b0ac-c1353a5c6c5e
[DOC] 2_mitosis_meiosis_20_ph.docx - Barley World,https://barleyworld.org/sites/barleyworld.org/files/2_mitosis_meiosis_20_ph.docx
[DOC] Priority question for written answer,https://www.europarl.europa.eu/doceo/document/P-9-2022-002494_EN.docx
[DOC] Bivalent Selection and Graded Darwinian Individuality Daniel J. Molter,http://philsci-archive.pitt.edu/16154/1/Bivalent_Selection_and_Graded_Darwinian_Individuality_06-07-2019_BJPS-2018-193.R3.docx
"[DOC] united states securities and exchange commission - Vaxart, Inc.",https://investors.vaxart.com/static-files/5d5c848d-610f-481e-87f1-8640139d15aa
"[DOC] Download DOC - Vaxart, Inc.",https://investors.vaxart.com/static-files/98f27294-9625-43c8-a11b-cb4c5ae391af
[DOC] HVTN 100 regimen - DOI,https://doi.org/10.1371/journal.pmed.1003117.s003
[DOC] Frequently Asked Questions about HPV and the Vaccine.docx,https://www.une.edu/sites/default/files/Frequently%2520Asked%2520Questions%2520about%2520HPV%2520and%2520the%2520Vaccine.docx
